Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Free Realtime Quote INR

Vivanza Biosciences Limited (VIVANZA.BO)

2.1800
-0.0500
(-2.24%)
As of 9:45:44 AM GMT+5:30. Market Open.
Loading Chart for VIVANZA.BO
  • Previous Close 2.2300
  • Open 2.1200
  • Bid 2.1900 x --
  • Ask 2.3000 x --
  • Day's Range 2.1200 - 2.3400
  • 52 Week Range 1.9000 - 7.8000
  • Volume 26,666
  • Avg. Volume 84,509
  • Market Cap (intraday) 87.2M
  • Beta (5Y Monthly) 0.97
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date May 7, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Vivanza Biosciences Limited engages in the research and development, manufacturing, and the distribution of pharmaceutical products in India. It offers latex surgical and examination, and latex free gloves, as well as other surgical products. The company was incorporated in 1982 and is based in Ahmedabad, India.

www.vivanzabiosciences.com

5

Full Time Employees

March 31

Fiscal Year Ends

Recent News: VIVANZA.BO

View More

Performance Overview: VIVANZA.BO

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

VIVANZA.BO
36.26%
S&P BSE SENSEX (^BSESN)
3.72%

1-Year Return

VIVANZA.BO
71.65%
S&P BSE SENSEX (^BSESN)
8.62%

3-Year Return

VIVANZA.BO
88.11%
S&P BSE SENSEX (^BSESN)
42.24%

5-Year Return

VIVANZA.BO
0.00%
S&P BSE SENSEX (^BSESN)
140.36%

Compare To: VIVANZA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VIVANZA.BO

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    89.20M

  • Enterprise Value

    149.88M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.79

  • Price/Book (mrq)

    1.81

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    33.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.80%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    113.49M

  • Net Income Avi to Common (ttm)

    -903k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.71M

  • Total Debt/Equity (mrq)

    126.82%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: VIVANZA.BO

View More

Company Insights: VIVANZA.BO

Research Reports: VIVANZA.BO

View More

People Also Watch